RPRX

Royalty Pharma plc

HealthcareBiotechnologyUSUSDPeers →

$55.29

LiveJun 11, 2026

AI Brief

Market cap

$23.78B

52w range

34.08 – 56.50

P / E

—

EPS

—

Volume

3.07M

Revenue · FY

—

Overview Fundamentals Market Narrative & AI

Explain this page

Arphra AIPlain-English read on Royalty Pharma plc’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$54.52

Change

+28.71%

Period high

$55.87

Period low

$42.36

Period start

$42.362026-02-02

Through 2026-06-10

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $56.67 (+2.50%)

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+1.41%	+0.04%	+7.05%	+18.42%	+42.46%	+43.09%	+62.38%	+68.52%	+23.14%	+24.25%	+24.25%

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Aftermarket

Live

Jun 11, 11:30 PM

Last trade

$55.58

Bid

$54.00

100 sh

Ask

$57.00

101 sh

Spread

$3.000

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Basic Materials
+2.94%
Technology
+2.09%
Utilities
+1.19%
Healthcare
+0.85%
Financial Services
+0.48%
Communication Services
-0.41%
Consumer Defensive
-0.59%
Industrials
-0.73%
Consumer Cyclical
-1.09%
Real Estate
-1.58%
Energy
-2.78%

Top industries (issuer's industry highlighted)

Biotechnology
+2.80%
Travel Services
+7.28%
Leisure
+6.11%
Computer Hardware
+5.11%
Engineering & Construction
+4.75%
Agricultural - Machinery
-4.52%
Furnishings, Fixtures & Appliances
+4.28%
Industrial - Machinery
-3.93%
Aerospace & Defense
+3.79%
Medical - Equipment & Services
+3.70%
Construction Materials
-3.39%
Auto - Parts
-3.34%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Peers

No peer list available for RPRX.

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin